The Oncology Institute (“TOI”) is proud to announce that our CEO, Brad Hively, has been named as a nominee for the LA Times’ CEO & CFO Leadership Awards. Mr. Hively has over 20 years of executive leadership and healthcare experience and has led TOI through several important milestones, including the recent announcement that TOI will become a publicly traded company. Prior to TOI, Brad led physician groups at Health Essentials and Heritage Provider Network and served on the Boards of The Oncology Institute, Biorasi, Patient Care America, and American Access Care.
Hively has long been a proponent of value-based healthcare and understood the potential it had, specifically in oncology. During his tenure, TOI has entered 3 new markets, taken responsibility for more than 500,000 new patient lives, developed a one-of-a-kind outpatient stem cell transplant program, and launched a best-in-class outpatient infusion program.
The 2021 CEO & CFO Leadership Awards are presented to leadership professionals in Los Angeles by the Los Angeles Times B2B Publishing Team for outstanding professional contributions to their organization. All honorees will be announced at a virtual event taking place on August 5, 2021.
You can also read about our CFO’s recent nomination for Orange County Business Journal’s CFO of the Year Awards here.
